Bayer AG · XETR:BAYN

Bayer — Fact Sheet (November 2024)

1 slide from Bayer's fact sheet, Nov 8, 2024

1. Slide 1: Pharmaceuticals – Pipeline Overview (as of November 08, 2024)

   Pharmaceuticals – Pipeline Overview1 (as of November 08, 2024) Phase I Phase II Phase III HER2/mEGFR Inhibitor (BAY 2927088) Congestive Heart Failure rAAV Gene Therapy (AB-1002) Darolutamide (AR Inhibitor) Congestive Heart Failure (GenePHIT) Adjuvant Prostate Cancer (DASL-HiCaP) DGKzeta Inhibitor (B

Bayer — Fact Sheet (November 2024) on 6ix